Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Makers, Activists Say MNCs Hide Facts In Patents

This article was originally published in PharmAsia News

Executive Summary

Major Indian drug makers are joining with public-health activists to accuse multinational drug companies of being less than forthcoming in their patent applications. The Indian groups say the MNCs are attempting to hide the identity of the molecules they use in their formulas. A patent expert said some companies attempt to call their creations "a novel compound" or "new pharmaceutical substance" to avoid identification of the chemicals or molecules involved. He said there are rules against accepting such applications, but said the rules are broken more often than they are followed. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts